Therapeutic Cannabinoids

Everyone is familiar with Dronabinol or Marinol, here is a listing and links to information on the 15 Cannabinoids that are currently registered with NIH.

Dronabinol - Dronabinol is a synthetic form of delta-9-tetrahydrocannabinol, a psychoactive substance found in Cannabis sativa. Dronabinol acts directly on the appetite and vomiting control centers in the brain to stimulate appetite and prevent emesis. - NIH LINK -

Palmitoylethanolamide - Anti-Inflammatory Agents, Non-Steroidal, Cannabinoid Receptor Agonists, Antiviral Agents, Analgesics - NIH LINK -

Rimonabant - an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. It is an inverse agonist for the cannabinoid receptor CB1. Its main avenue of effect is reduction in appetite. - NIH LINK -

Rimonabant hydrochloride - an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. It is an inverse agonist for the cannabinoid receptor CB1. Its main avenue of effect is reduction in appetite. - NIH LINK -

Anandamide - Calcium Channel Blockers - Cannabinoid Receptor Agonists - NIH LINK -

AM-679 (Cannabinoid) Use Of Flap Inhibitors To Reduce Neuroinflammation Mediated Injury In The Central Nervous System - NIH LINK -

9-Keto-cannabinoid methyl ether - No Description of it’s use is found - NIH LINK -

9-kcme - Dronabinol/analogs and derivatives Date introduced: September 4, 1991 - NIH LINK -

RCS-4 - Cannabinoid Receptor Agonists - Patented 2015-06-04 - NIH LINK -

AM-694 - Cannabinoid Receptor Agonists - Patented 2013-07-01 - NIH LINK -

Surinabant - Cannabinoid Receptor Antagonists - Several Patents - NIH LINK -

Ibipinabant - Cannabinoid Receptor Antagonists - Several Patents - NIH LINK -

Virodhamine - Cannabinoid Receptor Modulators - Several Patents - NIH LINK -

n-oleoylethanolamine - Cannabinoid Receptor Agonists - Several Patents - NIH LINK -

2-arachidonoylglycerol - Cannabinoid Receptor Agonists - Several Patents - NIH LINK -

**NOTE:  Cannabinoid Receptor Agonists,  Compounds that interact with and stimulate the activity of CANNABINOID RECEPTORS.